PartnerRe Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-6,537
Closed -$471K 233
2016
Q1
$471K Hold
6,537
0.24% 60
2015
Q4
$551K Sell
6,537
-11,118
-63% -$923K 0.28% 55
2015
Q3
$1.48M Buy
17,655
+15
+0.1% +$1.27K 0.25% 67
2015
Q2
$1.47M Sell
17,640
-3,076
-15% -$234K 0.28% 72
2015
Q1
$1.5M Sell
20,716
-151
-0.7% -$10.8K 0.25% 72
2014
Q4
$1.44M Buy
20,867
+2,872
+16% +$194K 0.24% 78
2014
Q3
$1.17M Sell
17,995
-2,951
-14% -$187K 0.23% 81
2014
Q2
$1.3M Sell
20,946
-2,867
-12% -$171K 0.23% 87
2014
Q1
$1.4M Sell
23,813
-53
-0.2% -$2.96K 0.24% 89
2013
Q4
$1.22M Sell
23,866
-1,403
-6% -$70.3K 0.21% 97
2013
Q3
$1.27M Sell
25,269
-3,336
-12% -$175K 0.21% 94
2013
Q2
$1.41M Buy
+28,605
New +$1.56M 0.23% 89

Other funds holding LLY

PartnerRe Asset Management's LLY Position: Q2 2016 in Review

PartnerRe Asset Management sold out of Eli Lilly (LLY) in Q2 2016, closing a stake of 6,537 shares — an estimated $471K sold.

PartnerRe Asset Management first reported a position in LLY in Q2 2013 and held it in 12 quarters. The position peaked at $1.5M in Q1 2015. 1,179 funds tracked by Wall St. Rank hold LLY as of Q2 2016.

  • PartnerRe Asset Management reported no remaining Eli Lilly position as of Q2 2016 after selling out during the quarter.
  • PartnerRe Asset Management sold 6,537 Eli Lilly shares in Q2 2016, an estimated $471K.
  • PartnerRe Asset Management first reported a position in Eli Lilly in Q2 2013 and held it in 12 quarters.
  • PartnerRe Asset Management's Eli Lilly position peaked at $1.5M in Q1 2015.
  • 1,179 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2016.

Based on PartnerRe Asset Management's 13F filing for Q2 2016, filed 14 Jul 2016.